Purchase Order 75N92019P00144
Award Date 5/17/19
Potential Completion Date 6/28/19
Potential Value $25K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Grand Island, NY 14072, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Agilent Technologies, Inc. for $12,036.15 on April 30, 2021, to procure Agilent SureSelect XT HS sequencing probes and kits for the Dunbar Lab. This sole-source acquisition supports sequencing of COVID patients for ARCH mutations. Place of performance is Marshallton, Delaware. The order is firm fixed price with an ultimate completion date of April 30, 2021.</p>
- <p>The National Heart Lung and Blood Institute issued a $38,844 delivery order to Illumina, Inc. on November 4, 2014, for genetic sequencing and genomic analysis equipment and materials, with an ultimate completion date of August 31, 2015.</p> <p>Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The source does not identify the parent vehicle under which this delivery order was issued.</p>
- <p>The National Heart Lung and Blood Institute issued a $31,987.71 delivery order to Illumina, Inc. on May 23, 2019, for genetic sequencing and genomic analysis equipment and services, with ultimate completion by September 2, 2020.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed-price with no set-aside designation.</p>
- <p>The National Heart Lung and Blood Institute issued a $45,211.40 delivery order to Illumina, Inc. on June 24, 2020, for genetic sequencing and genomic analysis equipment and consumables.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with an ultimate completion date of September 2, 2020. No set-aside was used. The source does not identify a parent IDIQ or GWAC vehicle for this delivery order.</p>
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $12,105.91 firm fixed price delivery order to Illumina, Inc. to provide DNA sequencing and genomics core requirements including Illumina library preparation kits. The place of performance is San Diego, California. The period of performance is from June 30, 2023 through September 29, 2023. The award supports the agency's biomedical research efforts by providing key...
- <p>The National Heart Lung and Blood Institute issued a $5,243 delivery order to Illumina, Inc. on July 8, 2015, for genetic sequencing reagents and consumables, with ultimate completion on July 17, 2015.</p> <p>Place of performance is Bethesda, MD. The order is firm fixed price with no set-aside.</p>
- <p>The National Heart Lung and Blood Institute issued a $108,771 delivery order to Illumina, Inc. on December 19, 2014, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order is firm fixed price with an ultimate completion date of August 31, 2015. The source does not identify the parent IDIQ or GWAC vehicle under which this delivery order was issued.</p>
- <p>The National Heart Lung and Blood Institute issued a $84,341 delivery order to Illumina, Inc. on July 6, 2015, for genetic sequencing and genomic analysis technologies on a firm fixed-price basis.</p> <p>Place of performance is Bethesda, MD. The order ceiling value is $84,341 with an ultimate completion date of August 31, 2015. No set-aside was used in this award.</p>
- <p>The National Heart Lung and Blood Institute issued a purchase order to Life Technologies Corporation for maintenance services on the Thermo Fisher 3500 Genetic Analyzer, valued at $56,546.41, awarded October 15, 2023. Work is performed in Bethesda, Maryland with an ultimate completion date of October 14, 2028. The order is priced firm fixed price with no small business set-aside.</p>
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for PCR and sequencing equipment valued at $18,648.00 on March 13, 2020, with final completion on August 21, 2020. The order is firm fixed price with no small business set-aside. Performance takes place in Cambridge, Massachusetts.</p>